echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Nat Med: Efficacy analysis of second dose of BNT162b2 for COVID-19 hospitalizations and deaths in adults over 60 years of age

    Nat Med: Efficacy analysis of second dose of BNT162b2 for COVID-19 hospitalizations and deaths in adults over 60 years of age

    • Last Update: 2022-05-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The B.


    COVID-19

    Recently, a research article was published in the top medical journal Nature Medicine.


    The researchers compared hospitalizations and mortality from COVID-19 in participants who received a second booster immunization


    immunity

    A total of 563,465 participants in the study met study eligibility and criteria


    The study showed that among Israeli adults aged 60 years and older, hospitalizations and deaths due to Covid-19 were significantly reduced as a result of a second booster vaccine


    Among Israeli adults aged 60 and older, hospitalizations and deaths due to Covid-19 have fallen sharply as a result of a second booster vaccine


    Original source:

    Ronen Arbel, et al.


    Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years

    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.